Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.

Simons SO, van der Laan T, Mulder A, van Ingen J, Rigouts L, Dekhuijzen PN, Boeree MJ, van Soolingen D.

Clin Microbiol Infect. 2014 Oct;20(10):1015-20. doi: 10.1111/1469-0691.12696. Epub 2014 Jul 16.

2.

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.

Sengstake S, Bergval IL, Schuitema AR, de Beer JL, Phelan J, de Zwaan R, Clark TG, van Soolingen D, Anthony RM.

BMC Infect Dis. 2017 Jul 12;17(1):491. doi: 10.1186/s12879-017-2594-3.

3.

Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.

Maslov DA, Zaĭchikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN.

Tuberculosis (Edinb). 2015 Sep;95(5):608-12. doi: 10.1016/j.tube.2015.05.013. Epub 2015 Jun 2.

PMID:
26071666
4.

Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.

Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A.

BMC Microbiol. 2010 Aug 20;10:223. doi: 10.1186/1471-2180-10-223. Erratum in: BMC Microbiol. 2010;10:278.

5.

Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.

Mphahlele M, Syre H, Valvatne H, Stavrum R, Mannsåker T, Muthivhi T, Weyer K, Fourie PB, Grewal HM.

J Clin Microbiol. 2008 Oct;46(10):3459-64. doi: 10.1128/JCM.00973-08. Epub 2008 Aug 27.

6.

Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.

Al-Mutairi NM, Ahmad S, Mokaddas E.

Int J Tuberc Lung Dis. 2011 Jan;15(1):110-5.

PMID:
21276306
7.

Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.

Abanda NN, Djieugoué JY, Lim E, Pefura-Yone EW, Mbacham WF, Vernet G, Penlap VM, Eyangoh SI, Taylor DW, Leke RGF.

BMC Infect Dis. 2017 May 31;17(1):379. doi: 10.1186/s12879-017-2489-3.

8.
9.

Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.

Kim HJ, Kwak HK, Lee J, Yun YJ, Lee JS, Lee MS, Min SY, Park SK, Kang HS, Maeng YH, Kim SY, Kim SY, Kook YH, Kim YR, Lee KH.

Int J Tuberc Lung Dis. 2012 Jan;16(1):98-103. doi: 10.5588/ijtld.10.0739.

PMID:
22236853
10.

Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Simons SO, van Ingen J, van der Laan T, Mulder A, Dekhuijzen PN, Boeree MJ, van Soolingen D.

J Clin Microbiol. 2012 Feb;50(2):428-34. doi: 10.1128/JCM.05435-11. Epub 2011 Nov 16.

11.

Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.

Gu Y, Yu X, Jiang G, Wang X, Ma Y, Li Y, Huang H.

Diagn Microbiol Infect Dis. 2016 Mar;84(3):207-11. doi: 10.1016/j.diagmicrobio.2015.10.017. Epub 2015 Oct 28.

PMID:
26775806
12.

The indirect microscopic observation drug susceptibility assay demonstrated high concordance with the indirect MGIT method for pyrazinamide susceptibility testing.

Wu X, Lu W, Shao Y, Liu Q, Shi X, Wang X, Li C, Zhu L, Chen C.

J Antimicrob Chemother. 2015 Aug;70(8):2295-9. doi: 10.1093/jac/dkv112. Epub 2015 May 7.

PMID:
25953803
13.

Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.

Tan Y, Hu Z, Zhang T, Cai X, Kuang H, Liu Y, Chen J, Yang F, Zhang K, Tan S, Zhao Y.

J Clin Microbiol. 2014 Jan;52(1):291-7. doi: 10.1128/JCM.01903-13. Epub 2013 Oct 16.

14.

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.

Mpagama SG, Houpt ER, Stroup S, Kumburu H, Gratz J, Kibiki GS, Heysell SK.

BMC Infect Dis. 2013 Sep 14;13:432. doi: 10.1186/1471-2334-13-432.

15.

Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.

Li D, Hu Y, Werngren J, Mansjö M, Zheng X, Drobniewski F, Hoffner S, Xu B.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5159-66. doi: 10.1128/AAC.02687-15. Print 2016 Sep.

16.

Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.

Maningi NE, Daum LT, Rodriguez JD, Mphahlele M, Peters RP, Fischer GW, Chambers JP, Fourie PB.

J Clin Microbiol. 2015 Dec;53(12):3779-83. doi: 10.1128/JCM.01179-15. Epub 2015 Sep 16.

17.

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.

Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Pym AS, Earl AM.

PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.

18.

[Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis].

Hong CY, Wang F, Liu XL.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Mar;36(3):198-201. Chinese.

PMID:
23856143
19.

Characterization of pncA gene mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Mexico.

Cuevas-Córdoba B, Xochihua-González SO, Cuellar A, Fuentes-Domínguez J, Zenteno-Cuevas R.

Infect Genet Evol. 2013 Oct;19:330-4. doi: 10.1016/j.meegid.2012.12.013. Epub 2013 Jan 12.

PMID:
23321280
20.

Clinical efficacy of direct DNA sequencing analysis on sputum specimens for early detection of drug-resistant Mycobacterium tuberculosis in a clinical setting.

Choi JH, Lee KW, Kang HR, Hwang YI, Jang S, Kim DG, Kim CH, Hyun IG, Shin TR, Park SM, Lee MG, Lee CY, Park YB, Jung KS.

Chest. 2010 Feb;137(2):393-400. doi: 10.1378/chest.09-0150. Epub 2009 Sep 9.

PMID:
19741059

Supplemental Content

Support Center